Join us for a webinar on January 26, 2023 at 7:00 pm for a presentation on "GLP-1 Receptor Agonists: Metabolic Effects and Their Role in Managing T2DM", held live online! This activity will inform clinicians about the pleiotropic effects of GLP-1 RAs, the demonstrated clinical efficacy of these agents for managing patients with T2DM and a variety of comorbid conditions, and guideline recommendations for incorporating GLP-1 RAs into management strategies for T2DM.
- Describe the pleiotropic mechanism of action of GLP-1 receptor agonists.
- Discuss efficacy and safety data for approved GLP-1 receptor agonists, including efficacy for glycemic and extra-glycemic effects.
- Incorporate GLP-1 receptor agonists into evidence-based individualized management plans for patients with type 2 diabetes aligned with current guideline recommendations.
Registration:
CME Accreditation
The AAFP has reviewed GLP-1 Receptor Agonists: Metabolic Effects and Their Role in Managing T2DM, and deemed it acceptable for AAFP credit. Term of approval is from 07/19/2022 to 06/15/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit or the evaluation, please email This email address is being protected from spambots. You need JavaScript enabled to view it..
